Blackline Inc.(BL)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BL Blackline Inc.

全国哀悼日 01-08 16:00:00 EST

57.09

-0.66

-1.14%

盘后57.09

+0.000.00%

17:36 EST

最高57.68	最低56.84	成交量50.06万
今开57.34	昨收57.75	日振幅1.45%
总市值35.67亿	流通市值29.70亿	总股本6,249万
成交额2,862万	换手率0.96%	流通股本5,202万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BL","market":"US","secType":"STK","nameCN":"Blackline Inc.","latestPrice":57.09,"timestamp":1736370000000,"preClose":57.75,"halted":0,"volume":500584,"hourTrading":{"tag":"盘后","latestPrice":57.09,"preClose":57.09,"latestTime":"17:36 EST","volume":78167,"amount":4462552.73,"timestamp":1736375797982},"delay":0,"floatShares":52015834,"shares":62485521,"eps":0.980199,"marketStatus":"全国哀悼日","change":-0.66,"latestTime":"01-08 16:00:00 EST","open":57.34,"high":57.6799,"low":56.84,"amount":28615556.477479998,"amplitude":0.014544,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.980199,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1736499600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1477627200000,"exchange":"NASDAQ","adjPreClose":57.75,"preHourTrading":{"tag":"盘前","latestPrice":57.41,"preClose":57.75,"latestTime":"09:29 EST","volume":239,"amount":13755.99872,"timestamp":1736346599999},"postHourTrading":{"tag":"盘后","latestPrice":57.09,"preClose":57.09,"latestTime":"17:36 EST","volume":78167,"amount":4462552.73,"timestamp":1736375797982},"volumeRatio":0.89517,"impliedVol":0.5197,"impliedVolPercentile":0.6032},"requestUrl":"/m/hq/s/BL/wiki","defaultTab":"wiki","newsList":[{"id":"2501662192","title":"Blackline, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501662192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501662192?lang=zh_cn&edition=full","pubTime":"2025-01-07 02:59","pubTimestamp":1736189972,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日02时59分，Blackline, Inc.股票出现波动，股价大幅跳水5.05%。Blackline, Inc.股票所在的软件服务行业中，整体涨幅为0.49%。其相关个股中，Arbe Robotics Ltd C/Wts 07/10/2026 、Nextplat Corp C/Wts 02/06/2027 、Aeye Inc C/Wts 30/09/2027 涨幅较大，Cerence Inc.、Arbe Robotics Ltd.、Intrusion Inc.较为活跃，换手率分别为137.78%、133.78%、84.88%，振幅较大的相关个股有Nextplat Corp C/Wts 02/06/2027 、Arbe Robotics Ltd C/Wts 07/10/2026 、Hub Cyber Security Ltd C/Wts 27/02/2028 ，振幅分别为156.48%、95.82%、70.00%。Blackline, Inc.公司简介：BlackLine Inc 致力于提供以软件即服务  形式交付的财务会计结算解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107025932aba0c071&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107025932aba0c071&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4023","BL","LU1815336091.USD","LU0757428866.USD"],"gpt_icon":0},{"id":"2500917405","title":"百利天恒(688506.SH)：注射用BL-B01D1被药审中心纳入突破性治疗品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2500917405","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500917405?lang=zh_cn&edition=full","pubTime":"2025-01-02 17:08","pubTimestamp":1735808923,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒 发布公告，公司自主研发的创新生物药注射用BL-B01D1用于既往经含铂化疗及抗PD-1/PD-L1单抗治疗失败的复发性小细胞肺癌患者已被国家药品监督管理局药品审评中心纳入突破性治疗品种名单，近日已完成公示。BL-B01D1是公司自主研发的全球首创也是唯一进入临床阶段的靶向EGFR×HER3的双抗ADC。BL-B01D1正在中国和美国进行超过20项针对多种肿瘤类型的临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1232507.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BL","688506","BK4023","LU0757428866.USD","LU1815336091.USD","BK0239"],"gpt_icon":0},{"id":"2486396776","title":"百利天恒(688506.SH)：BL-M08D1(ADC)临床试验申请获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2486396776","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486396776?lang=zh_cn&edition=full","pubTime":"2024-11-28 18:16","pubTimestamp":1732788963,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒(688506.SH)发布公告，公司于近日收到国家药品监督管理局(NMPA)正式批准签发的《药物临床试验批准通知书》,公司自主研发的创新生物药BL-M08D1(ADC)的药物临床试验获得批准。BL-M08D1是与BL-B01D1出自同一小分子技术平台、与BL-B01D1共享同一“连接子+毒素”平台的ADC药物，其适应症为复发或难治性血液系统恶性肿瘤和局部晚期或转移性实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","LU1815336091.USD","BK1141","BK0239","BK1583","ADC","BL","LU0757428866.USD","BK1576","03347","BK4023","688506","BK4231"],"gpt_icon":0},{"id":"2484971548","title":"Blackline, Inc.2024财年第三财季实现净利润17.24百万美元，同比增加44.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484971548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484971548?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773074,"startTime":"0","endTime":"0","summary":"11月17日，Blackline, Inc.公布财报，公告显示公司2024财年第三财季净利润为17.24百万美元，同比增加44.63%；其中营业收入为1.66亿美元，同比增加9.93%，每股基本收益为0.28美元。从资产负债表来看，Blackline, Inc.总负债12.98亿美元，其中短期债务3.98百万美元，资产负债比为1.31，流动比率为2.69。机构评级：截至2024年11月17日，当前有10家机构对Blackline, Inc.目标价做出预测，其中目标均价为63.20美元，其中最低目标价为50.00美元，最高目标价为81.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000559a23e07ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000559a23e07ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BL"],"gpt_icon":0},{"id":"2483630089","title":"美国研究综述-应用材料公司、迪士尼、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2483630089","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483630089?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:28","pubTimestamp":1731691712,"startTime":"0","endTime":"0","summary":"美国研究综述-应用材料公司、迪士尼、沃尔玛路透11月15日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括应用材料公司、迪士尼和沃尔玛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4T3MM1DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFG","BAC","AESI","LNG","AGYS","AAP","LU1074936037.SGD","IE00BKVL7J92.USD","BK4534","LU0868494708.USD","LU1032466523.USD","BLUE","BV","BRZE","BMY","LU1267930227.SGD","ADSK","AMH","IE00BBT3K403.USD","AHR","AAL","AIN","BK4588","BTM","AROC","ASTS","ASND","BL","BE","ALK","AGCO","ASB","BRX","LU0354030511.USD","AMAT","AKYA","ARE","BIIB","LU1861217088.USD","SCHW","ARI","BKR","BJ","ALGT","APH","AHCO","CAVA","CELC","CABA","CHX"],"gpt_icon":1},{"id":"2483435591","title":"激进投资者 Jana 减少对 Frontier 的投资，清算 QuidelOrtho 和 BlackLine","url":"https://stock-news.laohu8.com/highlight/detail?id=2483435591","media":"路透中文","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483435591?lang=zh_cn&edition=full","pubTime":"2024-11-15 06:01","pubTimestamp":1731621690,"startTime":"0","endTime":"0","summary":"激进投资者 Jana 减少对 Frontier 的投资，清算 QuidelOrtho 和 BlackLineSvea Herbst-Bayliss. 该对冲基金在周四 提交的 13-F 季度文件中称，它在第三季度出售了 570 万股 Frontier Communications FYBR.O的股票，减仓幅度达 59%。一年前，Jana 首次公开推动 Frontier 出售自己。Frontier 的股价在过去 52 周内攀升了 67.5%，并在 9 月初宣布 Verizon 交易时飙升 。该对冲基金还退出了第一季度建立的美国诊断公司QuidelOrtho  QDEL.O的头寸，以及第二季度建立的企业软件公司BlackLine Systems  BL.O的头寸。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4S3ML20O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU1066051811.HKD","BK4515","LU1815336091.USD","BK4023","BK4559","RPD","LU0868494617.USD","VZ","LU2384288077.EUR","LU0757428866.USD","LU0320765646.SGD","LU1621768206.USD","BK4198","BK4550","LU1878469433.USD","LU1914381329.SGD","LU0098860793.USD","BK4533","LU1571399168.USD","LU1621767737.EUR","LU1430594728.SGD","BK4115","LU1699723380.USD","BK4588","LU1585245621.USD","LU0306807586.USD","LU0306806265.USD","BL","LU1066051225.USD","LU1621767810.EUR","LU0868494708.USD","LU1066051498.USD","BK4097","LU1621768115.EUR","BK4082","IE00BSNM7G36.USD","LU1066053197.SGD","LU0225771236.USD","BK4585","LU0225284248.USD","LU0321505439.SGD","LU0321505868.SGD","LU0942090050.USD","BK4581","QDEL","LU1162221912.USD","BK4534","FYBR","LU1366192091.USD"],"gpt_icon":0},{"id":"2481927939","title":"百利天恒(688506.SH)：BL-M17D1(ADC)用于治疗晚期实体瘤患者的I期临床试验申请获得FDA许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2481927939","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481927939?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:24","pubTimestamp":1730971469,"startTime":"0","endTime":"0","summary":"智通财金APP讯，百利天恒 发布公告，近日，公司的全资子公司SystImmune,Inc.收到美国食品药品监督管理局的通知，BL-M17D1用于治疗晚期实体瘤患者的I期临床试验申请已获得FDA许可。BL-M17D1是与BL-B16D1出自同一新的小分子技术平台、与BL-B16D1共享同一新的“连接子+毒素”平台的ADC药物，其适应症为晚期实体瘤。包括本次BL-M17D1新获得FDA许可，截至目前，公司共有6个项目已获FDA许可开展临床研究，其他5个分别是：BL-B01D1、BL-M07D1、SI-B001、BL-M05D1、BL-M11D1在美国的临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","BK1141","03347","BK1583","BK4080","BL","LU0757428866.USD","BK0239","688506","BK1576","BK4023","ADC","LU1815336091.USD"],"gpt_icon":0},{"id":"2481839109","title":"Blackline, Inc.盘中异动 股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481839109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481839109?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903501,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Blackline, Inc.股票出现波动，股价大幅上涨5.30%。Blackline, Inc.股票所在的软件服务行业中，整体涨幅为1.09%。其相关个股中，Datchat, Inc.、Phunware, Inc.、Rumble Inc C/Wts 16/09/2027 涨幅较大，Datchat, Inc.、Phunware, Inc.、Earlyworks Co Ltd较为活跃，换手率分别为1137.93%、63.71%、35.11%，振幅较大的相关个股有Mogo Inc.、Rackspace Technology, Inc.、Soundthinking, Inc.，振幅分别为106.75%、106.25%、105.26%。Blackline, Inc.公司简介：BlackLine Inc 致力于提供以软件即服务  形式交付的财务会计结算解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223141a21d2a2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223141a21d2a2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BL","LU0757428866.USD","LU1815336091.USD","BK4023"],"gpt_icon":0},{"id":"2479942039","title":"美国研究综述-Altair 工程公司、布林克国际公司、梅塔公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2479942039","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479942039?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:41","pubTimestamp":1730385704,"startTime":"0","endTime":"0","summary":"    路透10月31日 - 华尔街证券分析师周四调整了对Altair Engineering、Brinker International和Meta等几家美国上市公司的评级和目标价。要闻 * Altair Engineering Inc   ：尼德姆将其评级从 \"买入 \"下调至 \"持有 * Blackbaud Inc   ：贝雅将其评级从 \"跑赢大盘 \"下调至 \"中性\"。* Brinker International Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Meta   ：贝尔德将目标价从605美元上调至630美元 以下是路透周四报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKNG","LU2264538146.SGD","IE00BMPRXR70.SGD","ATNI","BK4140","BMRC","CWH","ALKT","BK4141","CHRW","AVDL","LU1854104046.USD","IE00BFXG0V08.USD","BPMC","BRO","LU0061474960.USD","TECH","ATI","LU1169589451.USD","ANSS","BL","CDW","ALMS","ADP","AX","ALTR","ATEC","AXTA","AUR","BIIB","IE0009354923.USD","CAT","ALRS","META","EAT","AEIS","BIO","ALL","ABBV","BLKB","IE00BMPRXN33.USD","IE00BZ199S13.USD","ARCC","ALHC","ARVN","AVT","BG"],"gpt_icon":1},{"id":"2479792861","title":"国泰君安：黄金和金融板块的配置价值仍然值得重视","url":"https://stock-news.laohu8.com/highlight/detail?id=2479792861","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479792861?lang=zh_cn&edition=full","pubTime":"2024-10-31 08:34","pubTimestamp":1730334845,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0028","BK0183","518880","BK1564","BK4023","MGCmain","BK0201","SGUmain","159940","159934","02611","DUST","LU1815336091.USD","159831","BK0188","BK0012","GDX","SGCmain","BK1147","GLD","LU0757428866.USD","BK0276","601211","BL","NUGT","GCmain","BK0184","IAU"],"gpt_icon":0},{"id":"2475819736","title":"百利天恒：BL-M11D1临床试验申请获得美国FDA许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2475819736","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475819736?lang=zh_cn&edition=full","pubTime":"2024-10-13 16:36","pubTimestamp":1728808577,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1583","BK1141","BK4023","03347","BL","ADC","BK4231","BK1576","688506","LU1815336091.USD","LU0757428866.USD","BK0239","BK4080"],"gpt_icon":0},{"id":"2473126961","title":"百利天恒(688506.SH)：注射用BL-B01D1的2项适应症纳入突破性治疗品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2473126961","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473126961?lang=zh_cn&edition=full","pubTime":"2024-10-07 15:50","pubTimestamp":1728287450,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒 发布公告，公司自主研发的创新生物药注射用BL-B01D1用于经EGFR-TKI治疗失败的EGFR敏感突变的局部晚期或转移性非鳞状非小细胞肺癌患者以及用于治疗既往经抗PD-1/PD-L1单抗治疗且经含铂化疗治疗失败的局部晚期或转移性EGFR野生型非小细胞肺癌患者的2项适应症已被国家药品监督管理局药品审评中心纳入突破性治疗品种名单，近日已完成公示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1190481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BL","LU0757428866.USD","BK0239","688506","BK4023","LU1815336091.USD"],"gpt_icon":0},{"id":"2471220383","title":"Blackline, Inc.盘中异动 早盘急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471220383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471220383?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:36","pubTimestamp":1727703392,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时36分，Blackline, Inc.股票出现波动，股价急速上涨5.00%。Blackline, Inc.股票所在的软件服务行业中，整体涨幅为0.17%。Blackline, Inc.公司简介：BlackLine Inc 致力于提供以软件即服务  形式交付的财务会计结算解决方案。消息层面，截至21时36分，Blackline, Inc.股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930213633ab672773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930213633ab672773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","BL","BK4023","LU1815336091.USD"],"gpt_icon":0},{"id":"2471165852","title":"百利天恒BL-B01D1获临床研究新进展 合作方百时美施贵宝积极推进产品全球临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2471165852","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471165852?lang=zh_cn&edition=full","pubTime":"2024-09-29 23:47","pubTimestamp":1727624852,"startTime":"0","endTime":"0","summary":"9月27日盘后，百利天恒（SH688506，股价163.10元，市值654.03亿元）公告，合作方百时美施贵宝（以下简称BMS）获得美国食品药品监督管理局（以下简称FDA）通知，BL-B01D1联合用药项目用于治疗晚期实体瘤的1/2a期临床试验申请已获得FDA许可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202409293194499459.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202409293194499459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2125154778.USD","LU1670710588.SGD","LU2242646821.SGD","BK4581","IE00B2B36J28.USD","LU0882574055.USD","IE0009355771.USD","BK4023","BK4559","LU2133065610.SGD","LU1585245621.USD","LU1670711040.USD","BL","BK4007","LU0225771236.USD","LU1074936037.SGD","LU1670711123.USD","LU0237698245.USD","LU0757428866.USD","LU2125154935.USD","IE00BJJMRZ35.SGD","LU0061475181.USD","LU0456855351.SGD","LU2242652126.USD","LU2360032135.SGD","LU0114720955.EUR","LU0321505439.SGD","LU0306807586.USD","BK4532","IE00BJT1NW94.SGD","LU1032466523.USD","IE00BSNM7G36.USD","LU1093756168.USD","LU0225284248.USD","LU0868494617.USD","BMY","LU1261432733.SGD","LU1670710661.SGD","IE0002141913.USD","LU1989771016.USD","LU1815336091.USD","IE00BFTCPJ56.SGD","LU0306806265.USD","LU1093756325.SGD","BK4588","LU1291159041.SGD","BK4534","LU0985481810.HKD","LU1571399168.USD","LU0321505868.SGD"],"gpt_icon":0},{"id":"2471349888","title":"BRIEF-中国百利天恒：BL-B01D1联合用药项目相关临床试验申请获得FDA许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2471349888","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471349888?lang=zh_cn&edition=full","pubTime":"2024-09-29 18:58","pubTimestamp":1727607486,"startTime":"0","endTime":"0","summary":"BRIEF-中国百利天恒：BL-B01D1联合用药项目相关临床试验申请获得FDA许可路透北京9月29日 - 中国百利天恒688506.SS：* 合作伙伴百时美施贵宝BMY.N收到美国FDA通知，BL-B01D1联合用药项目用于治疗晚期实体瘤的1/2a期临床试验申请已获得FDA许可（完）公告全文，请点击此处 (发稿 刘珞焱) ((luoyan.liu@tr.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240929:nL4S3LB025:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688506","LU1815336091.USD","LU0757428866.USD","BL","BK4023"],"gpt_icon":0},{"id":"2471838018","title":"百利天恒(688506.SH)：BL-B01D1联合用药项目用于治疗晚期实体瘤1/2a期临床试验申请获FDA许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2471838018","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471838018?lang=zh_cn&edition=full","pubTime":"2024-09-29 16:54","pubTimestamp":1727600094,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒(688506.SH)公告，公司的合作伙伴百时美施贵宝收到美国食品药品监督管理局(“FDA”)的通知，BL-B01D1联合用药项目用于治疗晚期实体瘤的1/2a期临床试验申请已获得FDA许可。BL-B01D1是全球首创也是唯一进入临床阶段的靶向EGFR×HER3的双抗ADC。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1188619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0757428866.USD","BK0239","BK1583","688506","BL","LU1815336091.USD","BK4023","BK1576","03347","BK1141"],"gpt_icon":0},{"id":"2462433935","title":"谷歌Pixel 9系列手机被曝检测Root权限，解锁BL将导致部分AI功能无法使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2462433935","media":"IT之家","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462433935?lang=zh_cn&edition=full","pubTime":"2024-08-28 16:40","pubTimestamp":1724834449,"startTime":"0","endTime":"0","summary":"后续有更多用户测试发现，即使没有 Root，只要解锁了 BootLoader 引导加载程序也会导致 Pixel Screenshots 无法使用。如果禁用 AI 则可正常使用。除此之外，取消 Root 权限并重新锁定 BL 也可以恢复正常。此外，另一位用户表示自己解锁过的 Pixel 8 Pro 手机可以正常使用 Pixel Studio，这意味着目前似乎仅有 Pixel 9 系列机型存在限制。对于 Pixel Weather 也就是 AI 天气预报，这里的情况类似于 Pixel Screenshots，它在解锁 BL 的条件下同样会无法使用，但这项功能基本无用，因为用户可以直接询问 Gemini。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8cPylRwvSv1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4588","BK4023","LU0348723411.USD","BK4532","LU0006306889.USD","IE00BK4W5L77.USD","LU0234570918.USD","LU0308772762.SGD","LU0433182093.SGD","IE00BJLML261.HKD","LU0061475181.USD","BK4566","IE00BZ1G4Q59.USD","LU0048573561.USD","BK4551","BK4581","LU0072462426.USD","BK4534","IE00BKDWB100.SGD","BK4592","BK4587","BL","IE00BSNM7G36.USD","LU0096364046.USD","LU0127658192.USD","BK4550","IE00BKVL7J92.USD","BK4503","IE00B4JS1V06.HKD","GOOGL","IE0005OL40V9.USD","LU0225283273.USD","GOOG","LU0097036916.USD","BK4553","IE0004086264.USD","LU0170899867.USD","ROOT","LU0158827781.USD","IE00B5TLWC47.USD","BK4505","IE00B775SV38.USD","LU0289960550.SGD","BK4538","LU0154236417.USD","LU0203201768.USD","IE00BJTD4V19.USD","BK4585","IE00B1XK9C88.USD","IE00BFSS7M15.SGD"],"gpt_icon":1},{"id":"2460879692","title":"百利天恒(688506.SH)：BL-B01D1(EGFR×HER3-ADC)用于复发性小细胞肺癌III期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2460879692","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460879692?lang=zh_cn&edition=full","pubTime":"2024-08-18 15:33","pubTimestamp":1723966422,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒(688506.SH)公告，公司自主研发的创新生物药注射用BL-B01D1(EGFR×HER3-ADC)单药用于既往含铂化疗及抗PD-1/PD-L1单抗治疗失败的复发性小细胞肺癌的III期临床试验已于近日完成首例受试者入组。公告显示，BL-B01D1是公司自主研发的全球独家处于临床试验阶段的可同时靶向EGFR和HER3的双抗ADC药物。近日，BL-B01D1单药治疗既往含铂化疗及抗PD-1/PD-L1单抗治疗失败的复发性小细胞肺癌的临床研究已进入III期临床试验阶段并完成首例受试者入组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1165873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BL","BK4231","BK4023","03347","688506","III","ADC","BK1583","LU0757428866.USD","BK4134","LU1815336091.USD","BK0239","BK4080","BK1141","BK1576"],"gpt_icon":0},{"id":"2459517099","title":"激进投资者 Jana 第二季度增持 BlackLine Systems 股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2459517099","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459517099?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:15","pubTimestamp":1723644944,"startTime":"0","endTime":"0","summary":"    路透纽约8月14日 - 根据周三提交的一份监管文件，激进投资者 Jana Partners 在第二季度增持了美国企业软件公司 BlackLine Systems    的股份。文件显示，截至6月30日，Jana持有115万股，持股比例接近2%。文件显示，Jana持有少量Fortrea Holdings   的股份，在该季度末持有69万股。自从大约两年前 Jana 首次与该公司合作以来，其股价回报率约为 300%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4097","LU1878469433.USD","LU1941712348.USD","FYBR","LU0029874061.USD","LU1815336091.USD","LU0128526141.USD","FRPT","RPD","LU0053671581.USD","BK4023","QDEL","BK4212","FTRE","BK4198","BK4115","LU0757428866.USD","BK4082","LU0266013472.USD","LU1941712264.USD","BL"],"gpt_icon":0},{"id":"2458380697","title":"Blackline, Inc.2024财年第二财季实现净利润76.69百万美元，同比增加148.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458380697","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458380697?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:18","pubTimestamp":1723393136,"startTime":"0","endTime":"0","summary":"8月12日，Blackline, Inc.公布财报，公告显示公司2024财年第二财季净利润为76.69百万美元，同比增加148.59%；其中营业收入为1.61亿美元，同比增加11.03%，每股基本收益为1.24美元。从资产负债表来看，Blackline, Inc.总负债15.33亿美元，其中短期债务2.54亿美元，资产负债比为1.24，流动比率为1.96。机构评级：截至2024年8月12日，当前有11家机构对Blackline, Inc.目标价做出预测，其中目标均价为55.91美元，其中最低目标价为45.00美元，最高目标价为81.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120019079f222bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120019079f222bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blackline.com","stockEarnings":[{"period":"1week","weight":-0.0495},{"period":"1month","weight":-0.1009},{"period":"3month","weight":0.0424},{"period":"6month","weight":0.2059},{"period":"1year","weight":-0.0005},{"period":"ytd","weight":-0.0495}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":-0.0316},{"period":"3month","weight":0.0199},{"period":"6month","weight":0.0578},{"period":"1year","weight":0.2403},{"period":"ytd","weight":0.0044}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BlackLine, Inc.以BlackLine Systems, Inc之名成立于2001年。该公司已经创建了一个全面的基于云计算的软件平台，旨在为所有类型和规模的组织变革和现代化的会计和财务运作。他们的安全可扩展的平台支持关键会计流程，如财务结算，对账，公司间的会计和控制的保证等。通过引入软件来自动化这些流程并使其能够持续运行，他们授权客户提高其财务报告的完整性，提高效率并增强其运营的实时可见性。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.017977},{"month":2,"riseRate":0.5,"avgChangeRate":0.024013},{"month":3,"riseRate":0.25,"avgChangeRate":-0.046622},{"month":4,"riseRate":0.625,"avgChangeRate":0.016571},{"month":5,"riseRate":0.625,"avgChangeRate":0.000833},{"month":6,"riseRate":0.875,"avgChangeRate":0.035947},{"month":7,"riseRate":0.5,"avgChangeRate":0.001384},{"month":8,"riseRate":0.625,"avgChangeRate":0.032708},{"month":9,"riseRate":0.625,"avgChangeRate":0.017548},{"month":10,"riseRate":0.5,"avgChangeRate":-0.021421},{"month":11,"riseRate":0.777778,"avgChangeRate":0.10276},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.009734}],"exchange":"NASDAQ","name":"Blackline Inc.","nameEN":"Blackline Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Blackline Inc.(BL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Blackline Inc.(BL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Blackline Inc.,BL,Blackline Inc.股票,Blackline Inc.股票老虎,Blackline Inc.股票老虎国际,Blackline Inc.行情,Blackline Inc.股票行情,Blackline Inc.股价,Blackline Inc.股市,Blackline Inc.股票价格,Blackline Inc.股票交易,Blackline Inc.股票购买,Blackline Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Blackline Inc.(BL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Blackline Inc.(BL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况